Select your country Home About Products Business Development Capabilities Newsroom Report a Side Effect Contact R&D back The R&D team was established in 2002 and covers all areas of product development from formulation sciences, analytical services, regulatory expertise and support services. The facilities are spread over an area of ~ 57.000 Sq ft. The team has an enviable track record of successful development of generic medicines, high-barrier products and complex generics. Formulation development - a team of 50 highly qualified Formulation Scientists with expertise in the development of a wide range of dosage forms Tablets, Capsules, ER/SR/CR/MR/DR formulations, EVT Tablets, Pellets, Controlled release pellets Parenterals (Lyophilized & Liquid), Solutions, Suspensions, Emulsions Topicals (Ointments/creams/eye drops) New Drug delivery systems (Oral and parenteral) Excellent capabilities in Development of Cytotoxic & Potent drugs Handling Special Delivery Systems & Complex Manufacturing processes Scale up in Class 100.000 pilot manufacturing area Analytical Development - a team of 180 experienced analyst with expertise in: API characterization Analytical Method Development & Validation Dissolution Profiling Impurity Profiling Stability Study (ICH & Custom Condition) The scientists are supported by 60 regulatory personnel with expertise in dossier compilation and additional regulatory procedures compliant to EMA, FDA, ANVISA and other regulatory agencies. The R&D group have developed numerous novel technologies, formulations and processes covered by 27 international patents. Competition Law Modern Slavery Act Statement Legal Notices Privacy Policy Cookie Policy © Copyright Accord Healthcare External Link Icon About this tool External Link Icon Cookie Control